4Weiberger M. Sacks T, Sulkes J, et al, Increasing fungal isolation from clinical specimens: experience in a university hospital over a decade[J]. J Hosp Infect, 1997,35(1):185-188.
5张加芳，药物流行病学杂志，1997年，6卷，2期，95页
6Pfaller MA, Johnes RN, Messer SA, et al. National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE program[J]. Diagn Microbiol Infect Dis, 1998, 31(1):327-332.
7Price MF, LaRocco MT, Gentry LO, et al. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period[J].Antimicrob Agents Chemother,1994,38(6):1422-1427.
8Pfaller MA, Johnes RN, Messer SA, et al. National epidemiology of mycoses survey :a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species[J]. Diagn Microbiol Infect Dis,1998,31(1):289-296.
